systematic review raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2026-08-01 and is reviewed periodically as new material appears.
The name itself causes confusion, because several unrelated thymic peptides share the thymosin label. Thymosin beta-4, for example, is a different molecule with different functions. Naming conventions in the literature also mix descriptive research terms with assigned nonproprietary names, so a reader should confirm which entity a given paper addresses. Clarifying that point is usually the first step in interpreting any claim about this peptide.
Thymosin alpha-1 is a short peptide of 28 amino acid residues first described in the 1970s as a component of thymic extracts. Its N-terminal residue carries an acetyl group, and the sequence is highly conserved across mammalian species. The peptide is not encoded as a standalone gene product; it is released by proteolytic cleavage from the N-terminus of prothymosin alpha, a larger acidic nuclear protein. That precursor relationship places it within a broader family of thymic and immune-associated peptides that have been studied for decades.
The activity of this peptide is generally described as immunomodulatory rather than directly antimicrobial. Experimental work links it to signaling through certain Toll-like receptors on dendritic cells and to downstream maturation of antigen-presenting cells. Reported effects include expansion of T cell subsets, shifts in cytokine profiles, and increased natural killer cell activity. These observations come largely from cell culture and animal models, and the precise receptor-level events in humans remain incompletely characterized.
Thymosin alpha-1 is a 28-residue peptide first isolated from thymus tissue in the 1970s. It corresponds to the N-terminal portion of thymosin beta-4, from which it is cleaved in vivo. The peptide carries an acetyl group at its N-terminus, a modification that affects its charge and stability. Synthetic material produced by solid-phase peptide synthesis is chemically identical to the natural fragment and is the form used in research and clinical studies.
Laboratory work indicates that the peptide acts on cells of both the innate and adaptive immune systems. Reported effects include signalling through Toll-like receptors on dendritic cells, enhanced T-cell maturation, and increased natural killer cell activity. These actions are described largely from cell-culture and animal experiments, and the precise receptor-level events remain incompletely defined. Studies in humans have generally measured immune markers rather than a single defined molecular target. The resulting picture remains partly descriptive.
| Property | Value | Notes |
|---|---|---|
| Residue count | 28 amino acids | Acetyl group on the first residue |
| Approximate molecular mass | 3108 daltons | Calculated from the consensus sequence |
| Origin | Cleavage product of prothymosin alpha | Not encoded as a separate gene product |
| Primary research focus | Immune modulation | Studied in viral hepatitis and as a vaccine adjuvant |
| Common synonyms | Thymalfasin, Tα1, thymosin alpha 1 | Thymalfasin is the assigned nonproprietary name |
Identity and purity are assessed mainly by reversed-phase high-performance liquid chromatography, which separates the peptide from closely related impurities and from truncated or oxidized variants. Mass spectrometry supplies the molecular mass and confirms the expected sequence length, while amino acid analysis can be used to check composition. Because the molecule has no chromophore beyond the peptide backbone, ultraviolet detection is typically performed at a low wavelength, where baseline interference from solvents and buffers is a practical concern. Water content and counter-ion content are often reported alongside purity.
Practical handling focuses on limiting adsorption and contamination. The peptide dissolves readily in water, and dilute solutions tend to adhere to plastic and glass surfaces, so an inert carrier protein or a defined buffer can reduce losses in laboratory work. Workers also record the counter-ion form, since an acetate or trifluoroacetate salt changes the mass balance of the weighed powder. Documentation of lot number, purity value, and storage history supports reproducibility when results from different laboratories are compared.
Lyophilized material is generally held at reduced temperature to slow degradation, and storage at minus twenty degrees Celsius or lower is common practice for long-term retention. Short-term working portions are often kept between two and eight degrees Celsius. Once dissolved, the peptide is less stable than the dry powder, and repeated freeze-thaw cycles are associated with loss of material and with aggregate formation. Vials are usually allowed to reach room temperature before opening so that condensation does not introduce moisture, and solutions are protected from light where practical.
Thymosin alpha-1 is a synthetic peptide of 28 amino acids, corresponding to the N-terminal fragment of prothymosin alpha. Its sequence begins with acetylation at the N-terminus, a modification that affects stability and receptor interaction. The peptide is acidic, with a calculated isoelectric point near 4.2, and carries no disulfide bonds, so its secondary structure is largely flexible in solution. Molecular mass is approximately 3108 daltons. The native form was first isolated from bovine thymus tissue, while pharmaceutical material is produced by solid-phase peptide synthesis.
Within the immune system, the peptide acts on several cell types rather than a single target. Reported activities include promotion of T-cell maturation, enhancement of natural killer cell activity, and modulation of cytokine production by dendritic cells and macrophages. Some of these effects appear to operate through toll-like receptor signaling, though the precise receptor-level mechanism remains debated. Whether the observed immune changes translate into clinical benefit is a separate question and depends on the indication studied.
The peptide was described in the 1970s as a component of thymic extracts, and early research focused on restoring immune function in immunodeficiency states. A synthetic version entered clinical development in the 1980s and is approved as a drug in several countries for conditions such as chronic hepatitis B and certain immunodeficiencies. Approval status varies widely by jurisdiction, and in the United States it is not an approved therapeutic. Regulatory and clinical positions differ, so statements about efficacy should be tied to specific indications and studies.
Like most short peptides, thymosin alpha-1 is susceptible to hydrolysis under strongly acidic or basic conditions and to oxidation when exposed to air over long periods. The acetylated amino terminus blocks one common degradation route, which contributes to the molecule's relative robustness in solution. Lyophilized material generally retains potency for extended periods when kept cold and dry. Once reconstituted, aqueous solutions are less stable and are typically used within a defined window rather than held indefinitely at ambient temperature.
Routine handling calls for storage of the lyophilized powder at refrigerated temperatures, away from light, in a sealed container. Working solutions are often prepared in sterile water or buffer and kept cold between uses. Repeated freeze-thaw cycles are generally avoided because they can promote aggregation and loss of material. Laboratories usually record lot number, reconstitution date, and storage conditions so that any change in behavior can be traced to a specific preparation.
Reverse-phase high-performance liquid chromatography is the standard technique for assessing purity and concentration, because the peptide's hydrophobicity allows clean separation from related impurities. Mass spectrometry confirms molecular identity and detects sequence errors or truncations. Amino acid analysis and peptide mapping supply additional structural confirmation when required. Chromatographic purity values reported on certificates of analysis describe the proportion of the main peak and do not by themselves establish biological activity.
Clinical research has examined the peptide in chronic hepatitis B and C, as a vaccine adjuvant, and in sepsis and oncology settings. Findings across trials are mixed; some report changes in selected immune markers, while others find no clear clinical benefit. Many studies are small and define outcomes differently, which limits comparison. Regulatory approval is confined to a few countries, and the compound is not an approved drug in the United States or most of Europe.
Overall evidence quality varies considerably. A large share of published reports come from single centers, rely on surrogate immunological markers, or lack adequate control groups. Systematic reviews have highlighted this heterogeneity as a barrier to pooling results. Open questions include which patients, if any, might benefit, what treatment duration is appropriate, and whether any effect is independent of standard care. The peptide is often described as an immune modulator rather than a therapy for one disease, which complicates confirmatory trial design.
Lyubimov & Sablin (2026) report pathological modifications in a mandible of Canis etruscus from the Pleistocene strata from the Muhkai 2 locality (Dagestan, Russia) identified as a fully healed displaced mandibular fracture, and interpret the survival of the studied individual as a likely evidence of sociality and conspecific care in C. etruscus. Blázquez-Orta et al. (2026) study the fossil material of Early and Middle Pleistocene canids from the Atapuerca Mountains (Spain), interpret the morphology of the studied fossils as consistent with a gradual transition from Canis mosbachensis to the wolf, and determine the observed morphological changes to coincide with a climatic shift. Evidence from the study of tooth wear in late Pleistocene wolves from Britain, indicative of dietary shifts related to climate and environmental changes, is presented by Burtt et al. (2026). Micucci et al. (2026) compare the lengths and widths of carnassial teeth and overall body mass of Pleistocene grey wolves from eastern Beringia and recent Canadian individuals, find no evidence of significant body size differences between Pleistocene Yukon wolves and modern Canadian ones when accounting for sample size differences, and interpret Pleistocene Yukon wolves and modern Canadian wolves as belonging to the same ecotype, different from larger Pleistocene wolves from Alaska and Siberia.
Acetaldehyde (ethereal) Hexanal (green, grassy) cis-3-Hexenal (green tomatoes) Furfural (burnt oats) Hexyl cinnamaldehyde Isovaleraldehyde – nutty, fruity, cocoa-like Anisic aldehyde – floral, sweet, hawthorn. It is a crucial component of chocolate, vanilla, strawberry, raspberry, apricot, and others. Cuminaldehyde – Spicy, cumin-like, green
== Substrates == So far, more than 150 proteins have been identified to be targets for CK1-mediated phosphorylation, at least in vitro. Phosphorylation of numerous substrates is enabled due to the existence of several consensus motifs, which can be recognized by CK1 isoforms.
Sources: en.wikipedia.org
Muammar Muhammad Abu Minyar al-Gaddafi (c. 1942 – 20 October 2011) was a Libyan military officer, revolutionary, politician, and political theorist who ruled Libya from 1969 until his overthrow by Libyan rebel forces in 2011 during the First Libyan Civil War. He came to power through a bloodless military coup, first becoming Revolutionary Chairman of the Libyan Arab Republic from 1969 to 1977, Secretary General of the General People's Congress from 1977 to 1979, and then the Brotherly Leader of the Great Socialist People's Libyan Arab Jamahiriya from 1979 to 2011. Initially ideologically committed to Arab nationalism and Arab socialism, Gaddafi later ruled according to his own Third International Theory. Gaddafi became an Arab nationalist while at school in Sabha, later enrolling in the Royal Military Academy, Benghazi. He founded a revolutionary group known as the Free Officers movement which deposed the Western-backed Senussi monarchy of Idris I in a 1969 coup. Gaddafi converted Libya into a republic governed by his Revolutionary Command Council. Ruling by decree, he deported Libya's Italian population and ejected its Western military bases. He strengthened ties to Arab nationalist governments and unsuccessfully advocated pan-Arab political union. An Islamic modernist, he introduced Sharia law and promoted Islamic socialism. He nationalized the oil industry and used the increasing state revenues to bolster the military, fund foreign revolutionaries, and implement social programs emphasizing housebuilding, healthcare and education projects.
=== Muscle and fat tissue === Microwave burns show some similarities with electrical burns, as the tissue damage is deep rather than superficial. Adipose tissue shows less degree of damage than muscles and other water-rich tissues. (In contrast, radiant heat, contact burns and chemical burns damage subcutaneous adipose tissue to higher extent than deeper muscle tissue.) Full-thickness biopsy of the area between burned and unburned skin shows layers of more and less damaged tissue (tissue sparing), layers of undamaged fat between damaged muscles; a pattern that is not present in conventional thermal or chemical burns. Cells subjected to electrical burns show microscopic nuclear streaming on histology examination; this feature is not present with microwave burns. Microwaves also deposit more energy to areas with low blood supply and to tissue interfaces. Hot spots may be formed in the tissue, with a consequent higher absorption of microwave energy and even higher temperature achieved, with localized necrosis of the affected tissue following. Sometimes, the affected tissue can even be charred. Muscle tissue destruction can lead to myoglobinuria, with renal failure following in severe cases; this is similar to burns from electric current. Urinalysis and serum CPK, BUN and creatine tests are used to check for this condition.
=== KLOC === A computer programming expression, the K-LOC or KLOC, pronounced kay-lok, standing for "kilo-lines of code", i.e., thousand lines of code. The unit was used, especially by IBM managers, to express the amount of work required to develop a piece of software. Given that estimates of 20 lines of functional code per day per programmer were often used, it is apparent that 1 K-LOC could take one programmer as long as 50 working days, or 10 working weeks. This measure is no longer in widespread use because different computer languages require different numbers of lines to achieve the same result (occasionally the measure "assembly equivalent lines of code" is used, with appropriate conversion factors from the language actually used to assembly language). Error rates in programming are also measured in "Errors per K-LOC", which is called the defect density. NASA's SATC is one of the few organizations to claim zero defects in a large (>500K-LOC) project, for the space shuttle software. An alternative measurement was defined by Pegasus Mail author David Harris: the "WaP" is equivalent to 71,500 lines of program code, because that number of lines is the length of one edition of Leo Tolstoy's War and Peace.
advanced age cigarette smoking hypertension (high blood pressure) obesity hyperlipidemia, e.g. hypercholesterolemia, hypertriglyceridemia, elevated lipoprotein (a) or apolipoprotein B, or decreased levels of HDL cholesterol) diabetes mellitus Sedentary lifestyle stress Other important risk factors for arterial embolism include:
Sources: en.wikipedia.org
{\displaystyle {\begin{aligned}E_{\textrm {confinement}}&={\frac {\hbar ^{2}\pi ^{2}}{2a^{2}}}\left({\frac {1}{m_{\rm {e}}}}+{\frac {1}{m_{\rm {h}}}}\right)={\frac {\hbar ^{2}\pi ^{2}}{2\mu a^{2}}}\\[6px]E_{\textrm {exciton}}&=-{\frac {1}{\varepsilon _{\rm {r}}^{2}}}{\frac {\mu }{m_{\rm {e}}}}R_{y}=-R_{y}^{*}\\[6px]E&=E_{\textrm {bandgap}}+E_{\textrm {confinement}}+E_{\textrm {exciton}}\\&=E_{\textrm {bandgap}}+{\frac {\hbar ^{2}\pi ^{2}}{2\mu a^{2}}}-R_{y}^{*}\end{aligned}}}
YY.com, a major Chinese social network yy (digraph), digraph used in various Latin alphabets Yy (musician), Canadian musician YY, the call sign prefix for radio stations in Venezuela Y. Y., pseudonym of Robert Wilson Lynd (1879–1949), Irish essayist Peptide YY 3-36, a peptide secreted by the gut in response to a meal, and reduces appetite The Space Pirates, a 1969 Doctor Who serial (production code YY)
In the early 1960s, Mahathir visited Japan and witnessed its remarkable recovery from the devastation of Hiroshima and Nagasaki, symbolized by the 1964 Tokyo Olympics. Mahathir announced a "Look East" policy in December 1981. Under "Look East", Mahathir particularly prioritised relations with Japan, hoping this would bolster Malaysia's economy and that Japanese work ethic, values and moral norms would have a positive influence on Malaysians. He made over 100 visits to Japan. Consistent with the "Look East" strategy adopted under his leadership, there was a major push for heavy industries by Malaysia in the early 1980s.
Sources: en.wikipedia.org
It is usually classified as an immunomodulatory peptide rather than a classical hormone. It derives from the larger protein prothymosin alpha and acts mainly on immune cells. The thymosin label covers a group of distinct peptides, so the naming can be misleading.
The two share a family name but have different sequences, sizes, and functions. Thymosin beta-4 is a 43-residue peptide associated with actin binding and cell migration. Thymosin alpha-1 is a 28-residue peptide linked mainly to immune signaling.
Thymalfasin is the assigned international nonproprietary name for the synthetic 28-residue peptide. Thymosin alpha-1 is the descriptive research name for the same molecule. Which term appears depends on the context and the regulatory document.
It corresponds to the first 28 amino acids of thymosin beta-4, a larger protein found in many tissues. The fragment is acetylated at its N-terminus and is produced synthetically for research and pharmaceutical use. Synthetic and natural forms share the same sequence.